ANIP
Price
$82.67
Change
+$0.55 (+0.67%)
Updated
Dec 3 closing price
Capitalization
1.86B
84 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$13.96
Change
+$0.35 (+2.57%)
Updated
Dec 3 closing price
Capitalization
1.92B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANIP vs PRGO

Header iconANIP vs PRGO Comparison
Open Charts ANIP vs PRGOBanner chart's image
ANI Pharmaceuticals
Price$82.67
Change+$0.55 (+0.67%)
Volume$390.94K
Capitalization1.86B
Perrigo
Price$13.96
Change+$0.35 (+2.57%)
Volume$2.77M
Capitalization1.92B
ANIP vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
ANIP vs. PRGO commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ANIP: $82.17 vs. PRGO: $13.63)
Brand notoriety: ANIP and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ANIP: 24% vs. PRGO: 45%
Market capitalization -- ANIP: $1.86B vs. PRGO: $1.92B
ANIP [@Pharmaceuticals: Generic] is valued at $1.86B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $1.92B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • ANIP’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, ANIP is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 6 TA indicator(s) are bullish while PRGO’s TA Score has 5 bullish TA indicator(s).

  • ANIP’s TA Score: 6 bullish, 4 bearish.
  • PRGO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ANIP and PRGO are a good buy in the short-term.

Price Growth

ANIP (@Pharmaceuticals: Generic) experienced а -1.26% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +5.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.67%. For the same industry, the average monthly price growth was +0.42%, and the average quarterly price growth was +25.91%.

Reported Earning Dates

ANIP is expected to report earnings on Feb 26, 2026.

PRGO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.67% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($1.92B) and ANIP($1.86B) have the same market capitalization . PRGO has higher P/E ratio than ANIP: PRGO (2818.00) vs ANIP (51.67). ANIP YTD gains are higher at: 48.643 vs. PRGO (-45.197). PRGO has higher annual earnings (EBITDA): 612M vs. ANIP (89M). PRGO has more cash in the bank: 454M vs. ANIP (224M). ANIP has less debt than PRGO: ANIP (622M) vs PRGO (3.65B). PRGO has higher revenues than ANIP: PRGO (4.33B) vs ANIP (747M).
ANIPPRGOANIP / PRGO
Capitalization1.86B1.92B97%
EBITDA89M612M15%
Gain YTD48.643-45.197-108%
P/E Ratio51.672818.002%
Revenue747M4.33B17%
Total Cash224M454M49%
Total Debt622M3.65B17%
FUNDAMENTALS RATINGS
ANIP vs PRGO: Fundamental Ratings
ANIP
PRGO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
28100
SMR RATING
1..100
9191
PRICE GROWTH RATING
1..100
4894
P/E GROWTH RATING
1..100
462
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (95). This means that PRGO’s stock grew somewhat faster than ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (28) in the Pharmaceuticals Other industry is significantly better than the same rating for PRGO (100). This means that ANIP’s stock grew significantly faster than PRGO’s over the last 12 months.

ANIP's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as PRGO (91). This means that ANIP’s stock grew similarly to PRGO’s over the last 12 months.

ANIP's Price Growth Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (94). This means that ANIP’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for ANIP (46). This means that PRGO’s stock grew somewhat faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPPRGO
RSI
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 7 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
69%
Momentum
ODDS (%)
Bullish Trend 7 days ago
76%
Bearish Trend 7 days ago
67%
MACD
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 7 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
69%
Bearish Trend 7 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 9 days ago
60%
Declines
ODDS (%)
Bearish Trend 15 days ago
69%
Bearish Trend 15 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
60%
Aroon
ODDS (%)
Bearish Trend 7 days ago
66%
Bearish Trend 7 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
ANIP
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAEAX40.00N/A
N/A
Eaton Vance Tax-Managed Eq Aset Allc A
DCSYX69.56N/A
N/A
Davis Balanced Fund Y
PSPFX6.35N/A
N/A
US Global Investors Global Res
CRBRX14.70N/A
N/A
Columbia Acorn Inst2
VIHAX42.35N/A
N/A
Vanguard Intl Hi Div Yld Adm

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-2.72%
ORGO - ANIP
47%
Loosely correlated
-0.98%
AMRX - ANIP
32%
Poorly correlated
-2.48%
SNDL - ANIP
31%
Poorly correlated
+1.79%
PRGO - ANIP
29%
Poorly correlated
-1.59%
ANIK - ANIP
29%
Poorly correlated
-3.33%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ZTS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.59%
ZTS - PRGO
36%
Loosely correlated
-2.24%
ALKS - PRGO
33%
Poorly correlated
+0.24%
SUPN - PRGO
32%
Poorly correlated
-1.23%
EOLS - PRGO
32%
Poorly correlated
-4.40%
ORGO - PRGO
30%
Poorly correlated
-0.98%
More